Up­dat­ed: Flag­ship merges its trou­bled cir­cu­lar RNA com­pa­ny Laronde with nanopar­ti­cle start­up Sen­da

Laronde and Sen­da Bio­sciences, two biotech star­tups found­ed by Flag­ship Pi­o­neer­ing that col­lec­tive­ly raised more than $750 mil­lion, are merg­ing to form a new com­pa­ny …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER